GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SCWorx Corp (NAS:WORX) » Definitions » Debt-to-EBITDA

WORX (SCWorx) Debt-to-EBITDA : -0.03 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SCWorx Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SCWorx's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.04 Mil. SCWorx's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.01 Mil. SCWorx's annualized EBITDA for the quarter that ended in Sep. 2024 was $-1.57 Mil. SCWorx's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was -0.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SCWorx's Debt-to-EBITDA or its related term are showing as below:

WORX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.41   Med: -0.09   Max: -0.01
Current: -0.01

During the past 9 years, the highest Debt-to-EBITDA Ratio of SCWorx was -0.01. The lowest was -0.41. And the median was -0.09.

WORX's Debt-to-EBITDA is ranked worse than
100% of 447 companies
in the Healthcare Providers & Services industry
Industry Median: 2.36 vs WORX: -0.01

SCWorx Debt-to-EBITDA Historical Data

The historical data trend for SCWorx's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCWorx Debt-to-EBITDA Chart

SCWorx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only - -0.05 -0.12 -0.08 -0.02

SCWorx Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.01 -0.10 -0.31 -0.03

Competitive Comparison of SCWorx's Debt-to-EBITDA

For the Health Information Services subindustry, SCWorx's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCWorx's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SCWorx's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SCWorx's Debt-to-EBITDA falls into.



SCWorx Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SCWorx's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0.09) / -3.975
=-0.02

SCWorx's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.042 + 0.007) / -1.572
=-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


SCWorx  (NAS:WORX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SCWorx Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SCWorx's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SCWorx Business Description

Traded in Other Exchanges
Address
100 South Ashley Drive, Suite 100, Tampa, FL, USA, 33602
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
Executives
Vincent Michael Matozzo director 412 RICHARD LANE, ORANGE CT 06477
Christopher John Kohler officer: Chief Financial Officer 1149 CANTERBERRY LN, PARKER CO 80138
Steven Wallitt director C/O SCWORX CORP., 590 MADISON AVENUE, 21ST FLOOR, NEW YORK NY 10022
John C Ferrara director C/O EDGAR ONLINE, INC., 50 WASHINGTON STREET, NORWALK CT 06854
Steven Ross Horowitz director 4 MELISSA COURT, MONTVILLE NJ 07045
Marc Sanford Schessel director, 10 percent owner, officer: CEO 4 JACOBS LANE, NEW PALTZ NY 12561
Irby Alton F Iii director C/O MCKESSON CORP, ONE POST ST., SAN FRANCISCO CA 94104
Miller Charles Kenneth Iii director 100 METROPLEX, EDISON NJ 08817
Timothy Andrew Hannibal officer: President, COO 590 MADISON AVE, NEW YORK NY 10022
Mark Shefts director 160 SUMMIT AVE, MONTVALE NJ 07645
John C Price other: Former CFO 4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Robert Steven Christie director 34 SAN MARCO STREET, WEST WINDSOR NJ 08550
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
James Thaddeus Schweikert officer: Chief Operating Officer 7783 SOARING EAGLE CT., CINCINNATI OH 45244